AVERA ST MARYS — History
CCN 430015 | 3-year financial timeline | COVID resilience: 41/100
🛡️ Public data only — no PHI permitted on this instance.
$105M
Latest Revenue (FY2022)
+2.0%
Revenue CAGR (3yr)
-10.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $101M | $101M | $105M | +4.1% | +2.0% |
| Operating Expenses | $105M | $115M | $116M | +0.9% | +5.1% |
| Operating Margin | -4.2% | -14.2% | -10.6% | +25.2% | +0.0% |
| Net Income | $-4M | $-14M | $-11M | +22.2% | +0.0% |
| Licensed Beds | 50 | 50 | 50 | +0.0% | +0.0% |
| Total Patient Days | 5,675 | 5,820 | 6,043 | +3.8% | +3.2% |
| Medicare Day % | 49% | 45% | 45% | +0.4% | -3.8% |
| Medicaid Day % | 16% | 17% | 21% | +23.2% | +14.7% |
COVID Impact & Recovery
Resilience Score: 41/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +4.0% ($101M → $105M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.0%
This Hospital
+7.6%
State Avg
Latest Margin
-10.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $107M | -13.8% |
| FY2024 (proj) | $109M | -17.0% |
| FY2025 (proj) | $111M | -20.3% |